OP
OPRX.US OPTIMIZERx Corp
- Market cap
- USD 125M
- P/E
- 33.2x
- P/B
- 1.05x
- ROE
- 0.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is OPRX.US undervalued?
Graham numberOPRX.US trades 24.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
OPTIMIZERx Corp fundamental analysis
No fundamental analysis for OPTIMIZERx Corp yet.
OPTIMIZERx Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About OPTIMIZERx Corp
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messag…
Full company profileOPTIMIZERx Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
OPTIMIZERx Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 7.75M | 12.1M | 21.2M | 24.6M | 43.3M | 61.3M | 62.5M | 71.5M | 92.1M | 109M | 82.6M |
| Gross Profit | 4.34M | 5.95M | 12.2M | 15.4M | 24.1M | 35.6M | 39.0M | 42.9M | 59.4M | 69.3M | 61.1M |
| Operating Income | -1.58M | -2.13M | 180K | -3.69M | -2.14M | 361K | -12.3M | -26.4M | -13.7M | 12.1M | 3.97M |
| EBITDA | -1.30M | -1.81M | 1.24M | -1.40M | 752K | 2.34M | -9.42M | -21.3M | -8.90M | 16.6M | 8.64M |
| Net Income | -1.54M | -2.10M | 226K | -3.14M | -2.21M | 378K | -11.4M | -17.6M | -20.1M | 5.13M | -4.00K |
| EPS | -0.16 | -0.21 | 0.02 | -0.23 | -0.15 | 0.02 | -0.64 | -1.03 | -1.10 | 0.27 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 11.5M | 9.76M | 25.1M | 56.6M | 60.3M | 141M | 135M | 183M | 171M | 177M | 162M |
| Total Liabilities | 3.67M | 3.54M | 6.60M | 11.8M | 10.4M | 9.61M | 8.54M | 56.8M | 54.2M | 48.6M | 28.2M |
| Shareholders' Equity | 7.81M | 6.22M | 18.5M | 44.9M | 50.0M | 131M | 126M | 127M | 117M | 128M | 134M |
| Cash & Short-term Investments | 7.03M | 5.12M | 8.91M | 18.9M | 10.5M | 84.7M | 74.1M | 13.9M | 13.4M | 23.4M | 22.3M |
| Total Debt | - | - | - | 564K | 449K | 328K | 234K | 36.8M | 33.2M | 26.1M | 13.1M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -466K | -1.48M | 793K | -1.66M | -6.31M | 726K | 10.7M | -7.24M | 4.89M | 18.7M | 17.2M |
| Capital Expenditure | 350K | 42.2K | 91.0K | 1.59M | 125K | 486K | 245K | 871K | 112K | 58.0K | 90.7K |
| Free Cash Flow | -816K | -1.52M | 702K | -3.25M | -6.44M | 240K | 10.4M | -8.11M | 4.78M | 18.7M | 17.1M |
| Ratios | |||||||||||
| ROE | -19.7% | -33.8% | 1.2% | -7.0% | -4.4% | 0.3% | -9.1% | -13.9% | -17.2% | 4.0% | 0.0% |
| ROA | -13.4% | -21.5% | 0.9% | -5.5% | -3.7% | 0.3% | -8.5% | -9.6% | -11.7% | 2.9% | 0.0% |
| Net Profit Margin | -19.9% | -17.3% | 1.1% | -12.8% | -5.1% | 0.6% | -18.3% | -24.6% | -21.8% | 4.7% | 0.0% |
| Debt to Equity | - | - | - | 0.01x | 0.01x | 0.00x | 0.00x | 0.29x | 0.28x | 0.20x | 0.10x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
OPTIMIZERx Corp dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 226.00 | 0.00 | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:3 on May 14, 2018.
Who owns OPTIMIZERx Corp
- Insiders 13.95%
- Institutions 71.83%
- Public & others 14.21%
- Shares outstanding 18.8M
- Free float 14.5M
Top funds holding OPRX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Royce Small-Cap Opportunity Invmt | 672K | 3.57% | +31.83% | Sep 2026 |
| FTGF RY US SmCp Opp A USD Dis(A) | 631K | 3.35% | +3.07% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 494K | 2.62% | 0.00% | Sep 2026 |
| Jacob Internet Inv | 344K | 1.83% | +21.55% | Jun 2026 |
| DFA U.S. Small Cap Value I | 310K | 1.65% | +35.20% | Sep 2026 |
| PV BUYBACK USA Classe B USD | 89.2K | 0.47% | 0.00% | Jun 2026 |
| Jacob Discovery Fd Instl | 89.2K | 0.47% | +15.55% | Jun 2026 |
| Dimensional US Small Cap Value ETF | 80.8K | 0.43% | 0.00% | Sep 2026 |
| Fidelity Extended Market Index | 77.1K | 0.41% | -20.15% | Sep 2026 |
| Jacob Innovation Investor | 66.9K | 0.36% | +24.10% | Jun 2026 |
| Exemplar Growth and Income Ser FD | 66.0K | 0.35% | 0.00% | Oct 2026 |
| iShares Micro-Cap ETF | 49.9K | 0.26% | 0.00% | Oct 2026 |
| iShares Core S&P Total US Stock Mkt ETF | 46.3K | 0.25% | +0.03% | Oct 2026 |
| AQR Small Cap Multi-Style I | 44.5K | 0.24% | +642.86% | Jun 2026 |
| Fidelity Total Market Index | 29.0K | 0.15% | -0.06% | Sep 2026 |
| Fidelity Series Total Market Index | 25.0K | 0.13% | 0.00% | Sep 2026 |
| DFA US Micro Cap I | 22.6K | 0.12% | 0.00% | Sep 2026 |
| Venerable US Small Cap V | 22.3K | 0.12% | 0.00% | Oct 2026 |
| AQR Delphi L/S Eq IAU1F | 20.7K | 0.11% | -50.00% | Mar 2026 |
| Fidelity Global Micro-Cap F | 20.0K | 0.11% | -46.67% | Jun 2026 |
Top institutions holding OPRX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Whetstone Capital Advisors, LLC | 1.51M | 8.01% | 0.00% | Jun 2026 |
| Royce & Associates, LP | 1.09M | 5.78% | +22.68% | Jun 2026 |
| Vanguard Capital Management, LLC | 700K | 3.71% | +2.07% | Jun 2026 |
| Kennedy Capital Management Inc | 644K | 3.42% | -1.85% | Jun 2026 |
| Rice Hall James & Associates, LLC | 634K | 3.37% | +5.30% | Jun 2026 |
| Blair William & Co | 608K | 3.23% | -1.15% | Jun 2026 |
| AQR Capital Management LLC | 584K | 3.10% | +171.67% | Jun 2026 |
| BlackRock Inc | 445K | 2.36% | -61.72% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 443K | 2.35% | -7.26% | Sep 2026 |
| Parkman Healthcare Partners LLC | 350K | 1.86% | -51.97% | Jun 2026 |
| Awm Investment Company Inc | 240K | 1.28% | +4.34% | Jun 2026 |
| Geode Capital Management, LLC | 207K | 1.10% | -47.12% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 170K | 0.90% | -48.79% | Jun 2026 |
| Marshall Wace Asset Management Ltd | 162K | 0.86% | +418.40% | Jun 2026 |
| P.a.w. Capital Corp | 160K | 0.85% | +77.78% | Jun 2026 |
| Citadel Advisors Llc | 158K | 0.84% | 0.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 156K | 0.83% | +104.69% | Jun 2026 |
| Mink Brook Asset Management LLC | 141K | 0.75% | 0.00% | Jun 2026 |
| D. E. Shaw & Co LP | 138K | 0.73% | -3.39% | Jun 2026 |
| Janney Montgomery Scott LLC | 136K | 0.72% | 0.00% | Jun 2026 |
OPTIMIZERx Corp company profile
- Company name
- OPTIMIZERx Corp
- Ticker
- OPRX.US
- Exchange
- USA Stocks
- Listed since
- Oct 22, 1996
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 132
- Fiscal year end
- December
- Address
- 260 Charles Street, Waltham, MA, United States, 02453
- Phone
- 248 651 6568
- Website
- optimizerx.com
About OPTIMIZERx Corp
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.
OPTIMIZERx Corp management
10- Mr. Stephen L. SilvestroCEO & Director · born 1978
- Mr. Edward Stelmakh C.M.A., M.B.A.Chief Financial & Strategic Officer · born 1966
- Ms. Theresa GrecoAdvisor · born 1973
- Mr. Brendan MerrellChief Operating Officer · born 1985
- Ms. Marion K Odence-FordChief Legal & Administrative Officer · born 1965
- Ms. Maira AlejandraMedia Relations Manager
- Ms. Sarah BastChief Marketing Officer
- Mr. Andrew Jacob D'SilvaChief Business Officer · born 1986
- Jennifer DinkelSVP of Marketing
- Mr. Mike RouselleChief AI Officer